NUP214 and acute myeloid leukemia: According to a statistic in 2016, a total of 42 SET-CAN/NUP214 positive patients were reported up to that year, including T-ALL(38/42,90.5%), AUL(2/42,4.8%), AML(1/42;2.4%) and B-ALL(1/42;2.4%) (4), another study involving 59 T-ALL patients showed that about 10.3% of T-ALL patients carried SET-CAN/NUP214 fusion gene (20), Ben Abdelli et al.